Adenosquamous carcinoma of the digestive system: a literature review

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA: A Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Bosman F, Carneiro F, Hruban R, et al. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010.
   Google Scholar
• Lan YT, Huang KH, Liu CA, et al. A Nation-Wide Cancer Registry-based study of adenosquamous carcinoma in Taiwan. PLoS One. 2015;10(10):e0139748.
   PubMed Web of Science ®Google Scholar
• Li YL, Wen JF, Tang JW, et al. Pathology. 8th ed. Beijing: PMPH Press; 2013.
   Google Scholar
• Yachida S, Nakanishi Y, Shimoda T, et al. Adenosquamous carcinoma of the esophagus. Clinicopathologic study of 18 cases. Oncology. 2004;66(3):218–225.
   PubMed Web of Science ®Google Scholar
• Chen H, Shen C, Yin R, et al. Clinicopathological characteristics, diagnosis, treatment, and outcomes of primary gastric adenosquamous carcinoma. World J Surg Oncol. 2015;13:136.
   PubMed Web of Science ®Google Scholar
• Saito S, Hosoya Y, Morishima K, et al. A clinicopathological and immunohistochemical study of gastric cancer with squamous cell carcinoma components: a clinically aggressive tumor. J Dig Dis. 2012;13(8):407–413.
   PubMed Web of Science ®Google Scholar
• Nam KH, Kim JY. Primary adenosquamous carcinoma of the liver: a case report. Clin Mol Hepatol. 2016;22(4):503–508.
   PubMed Web of Science ®Google Scholar
• Woodard BH, Shelburne JD, Vollmer RT, et al. Mucoepidermoid carcinoma of the esophagus: a case report. Hum Pathol. 1978;9(3):352–354.
   PubMed Web of Science ®Google Scholar
• Mori M, Fukuda T, Enjoji M. Adenosquamous carcinoma of the stomach. Histogenetic and ultrastructural studies. Gastroenterology. 1987;92(4):1078–1082.
   PubMed Web of Science ®Google Scholar
• Cerezo L, Alvarez M, Edwards O, et al. Adenosquamous carcinoma of the colon. Dis Colon Rectum. 1985;28(8):597–603.
   PubMed Web of Science ®Google Scholar
• van Rees BP, Rouse RW, de Wit MJ, et al. Molecular evidence for the same clonal origin of both components of an adenosquamous Barrett carcinoma. Gastroenterology. 2002;122(3):784–788.
   PubMed Web of Science ®Google Scholar
• Noguchi T, Uchida Y, Fumoto S, et al. Adenosquamous carcinoma arising in Barrett's esophagus. Jpn J Thorac Cardiovasc Surg. 2002;50(12):537–540.
   PubMedGoogle Scholar
• Pera M, Brito MJ, Poulsom R, et al. Duodenal-content reflux esophagitis induces the development of glandular metaplasia and adenosquamous carcinoma in rats. Carcinogenesis. 2000;21(8):1587–1591.
   PubMed Web of Science ®Google Scholar
• Lee WA, Woo DK, Kim YI, et al. p53, p16 and RB expression in adenosquamous and squamous cell carcinomas of the stomach. Pathol Res Pract. 1999;195(11):747–752.
   PubMed Web of Science ®Google Scholar
• Fang Y, Su Z, Xie J, et al. Genomic signatures of pancreatic adenosquamous carcinoma (PASC). J Pathol. 2017;243(2):155–159.
   PubMed Web of Science ®Google Scholar
• Galuppini F, Salmaso R, Valentini E, et al. Adenosquamous gallbladder carcinoma: multigene hotspot mutational profiling reveals a monoclonal origin of the two components. Pathol Res Pract. 2017;213(8):1010–1013.
   PubMed Web of Science ®Google Scholar
• Milanetto AC, Valbona L, Alaggio R, et al. Adenosquamous carcinoma of the papilla of Vater: a phenotypic heterogeneity characterized by a common molecular landscape. Pathol Int. 2018;68(12):715–716.
   PubMed Web of Science ®Google Scholar
• Ohkuma M, Haraguchi N, Ishii H, et al. Absence of CD71 transferrin receptor characterizes human gastric adenosquamous carcinoma stem cells. Ann Surg Oncol. 2012;19(4):1357–1364.
   PubMed Web of Science ®Google Scholar
• Kure S, Matsuda Y, Hagio M, et al. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Int J Oncol. 2012;41(4):1314–1324.
   PubMed Web of Science ®Google Scholar
• Society JE. Japanese classification of esophageal cancer, 11th Edition. Esophagus. 2017;14(1):1–36.
   PubMed Web of Science ®Google Scholar
• Chen YY, Li AF, Huang KH, et al. Adenosquamous carcinoma of the stomach and review of the literature. Pathol Oncol Res. 2015;21(3):547–551.
   PubMed Web of Science ®Google Scholar
• Robert DO, Goldblum JR, Crawford JM. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. 2nd ed. Philadelphia: W.B. Saunders Company; 2009.
   Google Scholar
• Roa JC, Tapia O, Cakir A, et al. Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas. Modern pathology: an official journal of the United States and Canadian Academy of. Mod Pathol. 2011;24(8):1069–1078.
   PubMed Web of Science ®Google Scholar
• Voong KR, Davison J, Pawlik TM, et al. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol. 2010;41(1):113–122.
   PubMed Web of Science ®Google Scholar
• Na YJ, Shim KN, Cho MS, et al. Primary adenosquamous cell carcinoma of the pancreas: a case report with a review of the Korean literature. Korean J Intern Med. 2011;26(3):348–351.
   PubMedGoogle Scholar
• Kardon DE, Thompson LD, Przygodzki RM, et al. Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Modern pathology: an official journal of the United States and Canadian Academy of Pathology. Mod Pathol. 2001;14(5):443–451.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Okabayashi T, Okamoto K, et al. A clinicopathologic study of primary adenosquamous carcinoma of the liver. J Clin Gastroenterol. 2005;39(6):544–548.
   PubMed Web of Science ®Google Scholar
• Kass JI, Lee SC, Abberbock S, et al. Adenosquamous carcinoma of the head and neck: Molecular analysis using CRTC-MAML FISH and survival comparison with paired conventional squamous cell carcinoma. Laryngoscope. 2015;125(11):E371–E376.
   PubMed Web of Science ®Google Scholar
• Saeki K, Ohishi Y, Matsuda R, et al. Pancreatic mucoepidermoid carcinoma" is not a pancreatic counterpart of CRTC1/3-MAML2 fusion gene-related mucoepidermoid carcinoma of the salivary gland, and may more appropriately be termed pancreatic adenosquamous carcinoma with mucoepidermoid carcinoma-like features: Erratum. The American Journal of Surgical Pathology. 2019;43(5):723.
   PubMed Web of Science ®Google Scholar
• Kim J, Bowlby R, Mungall AJ, et al. Integrated genomic characterization of oesophageal carcinoma. Nature. 2017;541(7636):169–175.
   PubMed Web of Science ®Google Scholar
• Bailey P, Chang DK, Nones K, et al.; Australian Pancreatic Cancer Genome Initiative. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47–52.
   PubMed Web of Science ®Google Scholar
• Liu C, Karam R, Zhou Y, et al. The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma. Nat Med. 2014;20(6):596–598.
   PubMed Web of Science ®Google Scholar
• Gao S, Chen D, Huang L, et al. Primary adenosquamous carcinoma of the liver: a case report and review of the literature. Int J Clin Exp Pathol. 2015;8(8):9687–9692.
   PubMed Web of Science ®Google Scholar
• Akc M, Jiang R, Alese OB, et al. Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis. J Gastrointest Oncol. 2018;10(1):85–94.
   Web of Science ®Google Scholar
• Feng F, Zheng G, Qi J, et al. Clinicopathological features and prognosis of gastric adenosquamous carcinoma. Sci Rep. 2017;7(1):4597.
   PubMed Web of Science ®Google Scholar
• Evans M, Liu Y, Chen C, et al. Adenosquamous carcinoma of the esophagus: an NCDB-based investigation on comparative features and overall survival in a rare tumor. Oncology. 2017;93(5):336–342.
   PubMed Web of Science ®Google Scholar
• Fang Y, Pu N, Zhang L, et al. Chemoradiotherapy is associated with improved survival for resected pancreatic adenosquamous carcinoma: a retrospective cohort study from the SEER database. Ann Transl Med. 2019;7(20):522.
   PubMed Web of Science ®Google Scholar
• Fuchs CS, Tomasek J, Yong CJ, et al.; REGARD Trial Investigators. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014;383(9911):31–39.
   PubMed Web of Science ®Google Scholar
• Wilke H, Muro K, Van Cutsem E, et al.; RAINBOW Study Group. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014;15(11):1224–1235.
   PubMed Web of Science ®Google Scholar
• Tabernero J, Hozak RR, Yoshino T, et al. Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study. Ann Oncol. 2018;29(3):602–609.
   PubMed Web of Science ®Google Scholar
• Longo V, Brunetti O, Gnoni A, et al. Angiogenesis in pancreatic ductal adenocarcinoma: a controversial issue. Oncotarget. 2016;7(36):58649–58658.
   PubMedGoogle Scholar
• Imaoka H, Shimizu Y, Mizuno N, et al. Ring-enhancement pattern on contrast-enhanced CT predicts adenosquamous carcinoma of the pancreas: a matched case-control study. Pancreatology. 2014;14(3):221–226.
   PubMed Web of Science ®Google Scholar
• Toshima F, Inoue D, Yoshida K, et al. Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas. Abdom Radiol (NY). 2016;41(3):508–520.
   PubMed Web of Science ®Google Scholar
• Yin Q, Wang C, Wu Z, et al. Adenosquamous carcinoma of the pancreas: multidetector-row computed tomographic manifestations and tumor characteristics. J Comput Assist Tomogr. 2013;37(2):125–133.
   PubMed Web of Science ®Google Scholar
• Silvestris N, Danza K, Longo V, et al. Angiogenesis in adenosquamous cancer of pancreas. Oncotarget. 2017;8(56):95773–95779.
   PubMedGoogle Scholar
• Sawaki A, Ohashi Y, Omuro Y, et al. Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study. Gastric Cancer. 2012;15(3):313–322.
   PubMed Web of Science ®Google Scholar
• Kadowaki S, Yatabe Y, Nitta S, et al. Durable response of human epidermal growth factor receptor-2-positive gastric adenosquamous carcinoma to trastuzumab-based chemotherapy. Case Rep Oncol. 2014;7(1):210–216.
   PubMedGoogle Scholar
• Meric-Bernstam F, Hurwitz H, Raghav KPS, et al. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncol. 2019;20(4):518–530.
   PubMed Web of Science ®Google Scholar
• Sartore-Bianchi A, Trusolino L, Martino C, et al. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Lancet Oncol. 2016;17(6):738–746.
   PubMed Web of Science ®Google Scholar
• Maust JD, Frankowski-McGregor CL, Bankhead A, 3rd, et al. Cyclooxygenase-2 influences response to cotargeting of MEK and CDK4/6 in a subpopulation of pancreatic cancers. Mol Cancer Ther. 2018;17(12):2495–2506.
   PubMed Web of Science ®Google Scholar
• Weiss GJ, Liang WS, Demeure MJ, et al. A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges. PLoS One. 2013;8(10):e76438.
   PubMed Web of Science ®Google Scholar
• Albasri AM, Elkablawy MA, Ansari IA, et al. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study. Saudi Med J. 2019;40(5):432–439.
   PubMed Web of Science ®Google Scholar
• Song Y, Liu D, He G. TKTL1 and p63 are biomarkers for the poor prognosis of gastric cancer patients. CBM. 2015;15(5):591–597.
   Web of Science ®Google Scholar
• Kim K, Kim DH, Chae SW, et al. Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma. Pathol Oncol Res. 2014;20(2):409–415.
   PubMed Web of Science ®Google Scholar
• Wang W, Seeruttun SR, Fang C, et al. Prognostic significance of carcinoembryonic antigen staining in cancer tissues of gastric cancer patients. Ann Surg Oncol. 2016;23(4):1244–1251.
   PubMed Web of Science ®Google Scholar
• Ishida H, Miwa H, Tatsuta M, et al. Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer. Cancer Lett. 2004;207(1):109–115.
   PubMed Web of Science ®Google Scholar
• Dowaki S, Kijima H, Kashiwagi H, et al. CEA immunohistochemical localization is correlated with growth and metastasis of human gallbladder carcinoma. Int J Oncol. 2000;16(1):49–53.
   PubMed Web of Science ®Google Scholar
• Kim YS, Heo WS, Chae KH, et al. Clinicopathological features and differences of p53 and Ki-67 expression in adenosquamous and squamous cell carcinomas of the stomach. Kor J Gastroenterol. 2006;47(6):425–431.
   PubMedGoogle Scholar
• Wu ZC, Xiong L, Wang LX, et al. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder. World J Gastroenterol. 2017;23(14):2601–2612.
   PubMed Web of Science ®Google Scholar
• Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409–413.
   PubMed Web of Science ®Google Scholar
• Shen X, Zhao B. Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis. BMJ. 2018;362:k3529.
   PubMed Web of Science ®Google Scholar
• Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509–2520.
   PubMed Web of Science ®Google Scholar
• Vilar E, Tabernero J. Molecular dissection of microsatellite instable colorectal cancer. Cancer Discov. 2013;3(5):502–511.
   PubMed Web of Science ®Google Scholar
• Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev Clin Oncol. 2010;7(3):153–162.
   PubMed Web of Science ®Google Scholar
• Attiya AA, Almaghraby HQ, Satti MB. An unusual variant of adenocarcinoma of the left colon associated with microsatellite instability: a case report. Int J Surg Pathol. 2017;25(6):550–554.
   PubMed Web of Science ®Google Scholar
• Duncan VE, Harada S, Stevens TM. Primary colon adenosquamous carcinoma in a patient with lynch syndrome: a new histologic subtype associated with microsatellite instability? Int J Surg Pathol. 2016;24(7):653–655.
   PubMed Web of Science ®Google Scholar
• Woo DK, Lee WA, Kim YI, et al. Microsatellite instability and alteration of E2F-4 gene in adenosquamous and squamous cell carcinomas of the stomach. Pathol Int. 2000;50(9):690–695.
   PubMed Web of Science ®Google Scholar
• Silvestris N, Brunetti O, Pinto R, et al. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets. Expert Opin Ther Targets. 2018;22(5):453–461.
   PubMed Web of Science ®Google Scholar
• Hoadley KA, Yau C, Wolf DM, et al.; Cancer Genome Atlas Research Network. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014;158(4):929–944.
   PubMed Web of Science ®Google Scholar
• Borazanci E, Millis SZ, Korn R, et al. Adenosquamous carcinoma of the pancreas: molecular characterization of 23 patients along with a literature review. World J Gastrointest Oncol. 2015;7(9):132–140.
   PubMed Web of Science ®Google Scholar
• Li Y, Wang Z, Luo F. Clinic pathological features and survival of gastric adenocarcinoma. Chin J Clin Res. 2018;31(6):738–740.
   Google Scholar
• Schizas D, Kapsampelis P, Mylonas KM. Adenosquamous carcinoma of the esophagus: a literature review. J Transl Int Med. 2018;6(2):70–73.
   PubMed Web of Science ®Google Scholar
• Ge Y, Lin L, Ma X, et al. Adenosquamous carcinoma of the stomach: a population-based study from the SEER database. J Cancer. 2019;10(23):5705–5713.
   PubMed Web of Science ®Google Scholar
• Boyd CA, Benarroch-Gampel J, Sheffield KM, et al. 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res. 2012;174(1):12–19.
   PubMed Web of Science ®Google Scholar
• Masoomi H, Ziogas A, Lin BS, et al. Population-based evaluation of adenosquamous carcinoma of the colon and rectum. Dis Colon Rectum. 2012;55(5):509–514.
   PubMed Web of Science ®Google Scholar
• Yendamuri S, Malhotra U, Hennon M, et al. Clinical characteristics of adenosquamous esophageal carcinoma. J Gastrointest Oncol. 2017;8(1):89–95.
   PubMed Web of Science ®Google Scholar
• Ni PZ, Yang YS, Hu WP, et al. Primary adenosquamous carcinoma of the esophagus: an analysis of 39 cases. J Thorac Dis. 2016;8(10):2689–2696.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Chen CG, Gao YY, et al. Primary esophageal adenosquamous carcinoma: a retrospective analysis of 24 cases. Dis Esophagus. 2014;27(8):783–789.
   PubMed Web of Science ®Google Scholar
• Qin BD, Jiao XD, Yuan LY, et al. Adenosquamous carcinoma of the bile duct: a population-based study. Cancer Manag Res. 2018;10:439–446.
   PubMed Web of Science ®Google Scholar
• Endo K, Kohnoe S, Okamura T, et al. Gastric adenosquamous carcinoma producing granulocyte-colony stimulating factor. Gastric Cancer. 2005;8(3):173–177.
   PubMedGoogle Scholar
• Yoshida K, Manabe T, Tsunoda T, et al. Early gastric cancer of adenosquamous carcinoma type: report of a case and review of literature. Jpn J Clin Oncol. 1996;26(4):252–257.
   PubMed Web of Science ®Google Scholar
• Lemura A, Yano H, Mizoguchi A, et al. A cholangiocellular carcinoma nude mouse strain showing histologic alteration from adenocarcinoma to squamous cell carcinoma. Cancer. 1992;70(2):415–422.
   PubMed Web of Science ®Google Scholar
• Honda O, Johkoh T, Sekiguchi J, et al. Doubling time of lung cancer determined using three-dimensional volumetric software: comparison of squamous cell carcinoma and adenocarcinoma. Lung Cancer (Amsterdam, Netherlands). 2009;66(2):211–217.
   PubMed Web of Science ®Google Scholar
• Yan L, Xie F, Yang C, et al. The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma. World J Surg Oncol. 2015;13:90.
   PubMed Web of Science ®Google Scholar
• Toumi O, Hamida B, Njima M, et al. Adenosquamous carcinoma of the right colon: a case report and review of the literature. Int J Surg Case Rep. 2018;50:119–121.
   PubMed Web of Science ®Google Scholar
• Katz MH, Taylor TH, Al-Refaie WB, et al. Adenosquamous versus adenocarcinoma of the pancreas: a population-based outcomes analysis. J Gastrointest Surg. 2011;15(1):165–174.
   PubMed Web of Science ®Google Scholar
• Li B, Sun L, Wang X, et al. Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20(2):207–212.
   PubMedGoogle Scholar
• Geantă M, Cioroboiu C. The FDA changed everything. Biomed Hub. 2017;2(Suppl 1):52–54.
   PubMedGoogle Scholar